PanoramicaGraficoNotizieSchermataTrader

Morgan Stanley Discount Zert BNTX.../  DE000ME5LM99  /

Stuttgart
20/12/2024  21:50:31 Var.- Denaro22:00:35 Lettera22:00:35 Sottostante Prezzo di esercizio Expiration date Tipo di opzione
60.67EUR - -
Quantità in denaro: -		 -
Quantità in lettera: -		 BioNTech SE - USD 31/12/2024 Call
TeleTrader 04/11 BioNTech's revenue at €1.2 billion in Q3
TeleTrader 04/11 Earnings preview: Palantir, Aramco and more in action-packed week
GlobeNewswire 29/08 Advanced Medical Balloons appoints top-performing US life-science executive to drive business growth
GlobeNewswire 29/08 Medigene AG Secures Two Additional Patents for Technologies in Its End-to-End Platform
TeleTrader 22/08 FDA okays Moderna, Pfizer updated vaccines
GlobeNewswire 22/08 Pfizer and BioNTech Receive U.S. FDA Approval & Authorization for Omicron KP.2-adapted COVID-19 Vacc...
GlobeNewswire 16/08 Pfizer and BioNTech Provide Update on mRNA-based Combination Vaccine Program Against Influenza and C...
GlobeNewswire 14/08 Matinas BioPharma Reports Second Quarter 2024 Financial Results and Provides a Business Update
GlobeNewswire 08/08 Genmab Announces Financial Results for the First Half of 2024
GlobeNewswire 08/08 Genmab Updates 2024 Financial Guidance
TeleTrader 05/08 BioNTech posts revenue at €128.7 billion in Q2
GlobeNewswire 05/08 BioNTech Announces Second Quarter 2024 Financial Results and Corporate Update
GlobeNewswire 05/08 Genmab Takes Full Control of Acasunlimab Development Program
GlobeNewswire 01/08 Arbutus Reports Second Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire 30/07 BioNTech Announces Positive Topline Phase 2 Results for mRNA Immunotherapy Candidate BNT111 in Patie...
GlobeNewswire 22/07 BioNTech to Report Second Quarter 2024 Financial Results and Corporate Update on August 5, 2024
GlobeNewswire 27/06 Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron JN.1-adapted COVID-19 Vaccine in the E...
GlobeNewswire 24/06 BioNTech and DualityBio Receive FDA Fast Track Designation for Antibody-Drug Conjugate Candidate BNT...
GlobeNewswire 01/06 Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates M...
GlobeNewswire 29/05 BioNTech and CEPI Expand Partnership to Strengthen Africa’s mRNA Vaccine Ecosystem
GlobeNewswire 28/05 Medigene AG Expands its End-to-End Platform by Submitting Three Development Optimization Technology ...
GlobeNewswire 21/05 BioNTech to Present Clinical Data Updates for Next-Generation Immunotherapy Candidates at the ASCO A...
GlobeNewswire 21/05 Medigene's Global Research & Collaboration Agreement with BioNTech to Extend Beyond Initially Announ...
GlobeNewswire 17/05 BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2024
GlobeNewswire 17/05 Autolus Therapeutics Reports First Quarter 2024 Financial Results and Business Updates